Obstructive sleep apnea (OSA) is a very common pathology (it affects 25% of the population) that entails a number of risks for health of the patients.
OSA consists of the repetition during sleep of a transient (of at least 10 seconds) closure of the upper airway, blocking the passage of air (apnoea) or limiting it (hypopnoea).
The APNiA system is the only one on the market that allows diagnosis and subsequent treatment. It consists of an electronic device that performs the sleep study, diagnosis software and an intraoral device to treat to the patient.
